Paroxysmale nächtliche Hämoglobinurie
- 20 October 2021
- journal article
- Published by Springer Science and Business Media LLC in InFo Hämatologie + Onkologie
- Vol. 24 (10), 26-30
- https://doi.org/10.1007/s15004-021-8810-8
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatmentHematology, 2018
- ICCS/ESCCA Consensus Guidelines to detect GPI‐deficient cells in Paroxysmal Nocturnal Hemoglobinuria (PNH) and related Disorders Part 1 – Clinical UtilityCytometry Part B: Clinical Cytometry, 2018
- Paroxysmal nocturnal haemoglobinuriaNature Reviews Disease Primers, 2017
- Paroxysmal nocturnal hemoglobinuriaBlood, 2014
- Genetic Variants in C5 and Poor Response to EculizumabThe New England Journal of Medicine, 2014
- Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuriaBritish Journal of Haematology, 2013
- Under‐recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular functionBritish Journal of Haematology, 2012
- Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survivalBlood, 2011
- Paroxysmal Nocturnal Hemoglobinuria — Hemolysis before and after EculizumabThe New England Journal of Medicine, 2010
- Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumabBlood, 2009